COVID-19 in persons with multiple sclerosis treated with ocrelizumab – A pharmacovigilance case series

Detalles Bibliográficos
Autores principales: Hughes, Richard, Pedotti, Rosetta, Koendgen, Harold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228884/
https://www.ncbi.nlm.nih.gov/pubmed/32570202
http://dx.doi.org/10.1016/j.msard.2020.102192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228884/
https://www.ncbi.nlm.nih.gov/pubmed/32570202
http://dx.doi.org/10.1016/j.msard.2020.102192

Ejemplares similares